Tag: Insulet
Insulet sees ‘robust’ Q3
November 8, 2024HME News Staff
ACTON, Mass. – Insulet reported revenue of $543.9 million for the third quarter of 2023, an increase of 25.7%. Total Omnipod revenue was $533.6 million, an increase of 26.4%; of that, U.S. Omnipod revenue was $395.6 million and international Omnipod revenue was $138 million. “We continue to achieve significant milestones and robust revenue growth," said Jim Hollingshead, president and CEO. “Omnipod 5 is the first and only automated insulin delivery system in the U.S. for both...
Insulet to mark National Diabetes Awareness month
November 6, 2024HME News Staff
ACTON, Mass. – Insulet will recognize National Diabetes Awareness Month and World Diabetes Day with a series of activities in November. The company will sponsor the American Diabetes Association’s two-day community event Nov. 22 – 23 in Boston and will exhibit at the ADA Community Day of Access, which includes free health care screenings and more. “People with diabetes must make dozens of decisions every day to manage their condition, which can be incredibly stressful, overwhelming...
Omnipod 5 cleared for Type 2 diabetes management
August 28, 2024HME News Staff
ACTON, Mass. – Insulet has received clearance from the U.S. Food and Drug Administration for its Omnipod 5 Automated Insulin Delivery System for people with Type 2 diabetes, making it the only such device cleared by the FDA for both Type 1 and Type 2 diabetes management. “Today’s announcement represents a significant milestone in providing easy-to-use, patient-centric technology for the treatment of Type 2 diabetes,” said Jim Hollingshead, Insulet president and CEO. “Insulet...
In brief: OPGA names finalists, Insulet grows, Breas corrects
August 14, 2024HME News Staff
WATERLOO, Iowa – The Orthotic and Prosthetic Group of America has announced the four finalists nominated for the 2024 O&P Woman of the Year Award.
The finalists are:
Dr. Justina Appel, PhD, CO, BOCP, LPO, clinical specialist with NuTech Synergies;
Jenna Calomeris, vice president of sales with ThorWear, DBA Elevate Movement;
Dr. Sara Peterson, PhD, L/CPO, FAAOP(D), clinical research scientist/certified prosthetist orthotist (CPO) with O&P Clinical Innovations;...
Insulet: ‘2024 is shaping up to be another year of rapid growth’
August 13, 2024HME News Staff
ACTON, Mass. – Insulet has reported revenue of $488.5 million for the second quarter of 2024, a 23.2% increase year over year, exceeding the high end of the company’s guidance, driven by outperformance for all product lines.
Total Omnipod revenue was $480.4 million, a 26.3% increase, including $352.3 million in the U.S., a 27.3% increase.
“2024 is shaping up to be another year of rapid growth, fueled by strong Omnipod 5 demand and our accelerating pace of product...
In brief: Philips sues SoClean – again, AAH re-engages lawmakers, Enos re-enters sleep market
May 17, 2024HME News Staff
PITTSBURGH – Philips has sued SoClean in a bid to get the company, whose ozone cleaners it says “attacks” the foam in its CPAP devices, to pay part of its recently announced $1.1 billion settlement.
Philips announced the settlement in April to resolve the personal injury litigation and the medical monitoring class action related to a recall of certain sleep and respiratory devices in the U.S.
“(SoClean’s) negligent and intentionally misleading...
Insulet reports earnings increase, gains market share
May 15, 2024HME News Staff
ACTON, Mass. – Insulet reported revenue of $441.7 million for the first quarter 2024, an increase of 23.3% compared to the prior year. Total Omnipod revenue was $433.0 million, an increase of 21.1%, with U.S. Omnipod revenue $317.7 million. “We are pleased with our strong first quarter results, which underscore the strength of our advanced technology platform and deep competitive advantages,” said Jim Hollingshead, president and CEO. “During the quarter, we achieved strong...
Insulet’s Omnipod fuels growth
February 23, 2024HME News Staff
ACTON, Mass. – Insulet reported full year 2023 revenues $1.7 billion, up 30% compared to 2022. Fourth quarter 2023 revenue was $509.8 million, up nearly 38%. Total Omnipod revenue was $501 million; of that, US Omnipod revenue was $394.6 million, an increase of nearly 43%. “2023 was another transformational year for Insulet,” said Jim Hollingshead, president & CEO. “The rapid adoption of Omnipod 5 helped fuel our eighth consecutive year of more than 20% constant currency revenue...
Insulet gets FDA clearance for iPhone app
October 24, 2023HME News Staff
ACTON, Mass. – Insulet has received 510(k) clearance from the U.S. Food and Drug Administration for its Omnipod 5 App for iPhone, making Insulet the first company to offer a tubeless automated insulin delivery (AID) system with full control from a compatible Android and iOS smartphone. "Today, we celebrate this significant milestone in our ongoing effort to provide people with diabetes solutions that improve their lives and help them think less about diabetes," said Eric Benjamin, executive...
ResMed, AdaptHealth make tech list
January 26, 2023HME News Staff
YARMOUTH, Maine – Several HME companies have made the Power 500 Technology Companies list, a nod to their commitment to improving the health of people around the world. In the Medical Devices category, ResMed, Dexcom, Insulet Corp., AdaptHealth and Masimo were all listed as leaders. The list includes companies that demonstrate product or service leadership, technical depth in their specific fields, consistent organizational growth or evolution, operational excellence and high-caliber management...